Morgan Stanley analyst Benjamin Swinburne maintains Lamar Advertising (NASDAQ:LAMR) with a Equal-Weight and raises the price target from $103 to $110.
Why Oramed Pharmaceuticals Shares Are Trading Higher Today
Oramed Pharmaceuticals Inc (NASDAQ: ORMP) shares are trading higher after its partner completed Phase 3 trials of oral insulin in type 2 diabetes in China